Literature DB >> 8499622

Differentiation and proliferation of hematopoietic stem cells.

M Ogawa1.   

Abstract

Available evidence indicates that qualitative changes in hematopoietic stem cells and progenitors, such as the decision of stem cells to self-renew or differentiate, or selection of lineage potentials by the multipotential progenitors during differentiation (commitment), are intrinsic properties of the progenitors and are stochastic in nature. In-contrast, proliferative kinetics of the progenitors, namely survival and expansion of the progenitors, appear to be controlled by a number of interacting cytokines. While proliferation and maturation of committed progenitors is controlled by late-acting lineage-specific factors such as Ep, M-CSF, G-CSF, and IL-5, progenitors at earlier stages of development are controlled by a group of several overlapping cytokines. IL-3, GM-CSF, and IL-4 regulate proliferation of multipotential progenitors only after they exit from G0 and begin active cell proliferation. Triggering of cycling by dormant primitive progenitors and maintenance of B-cell potential of the primitive progenitors appears to require interactions of early acting cytokines including IL-6, G-CSF, IL-11, IL-12, LIF, and SF. Currently, this simple model fits our understanding of the interactions of growth factors with hematopoietic progenitors. Naturally the model risks oversimplification of a very complex process. However, because the model is testable, it will hopefully challenge investigators to design new experiments to examine its validity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499622

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  186 in total

1.  Enhancer-dependent transcriptional oscillations in mouse erythroleukemia cells.

Authors:  Y Q Feng; R Alami; E E Bouhassira
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells.

Authors:  Kohshi Ohishi; Barbara Varnum-Finney; Irwin D Bernstein
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

3.  Diabetes impairs the interactions between long-term hematopoietic stem cells and osteopontin-positive cells in the endosteal niche of mouse bone marrow.

Authors:  Hironori Chiba; Koji Ataka; Kousuke Iba; Kanna Nagaishi; Toshihiko Yamashita; Mineko Fujimiya
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-24       Impact factor: 4.249

4.  Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.

Authors:  Sara L Montgomery; Michael A Mastrangelo; Diala Habib; Wade C Narrow; Sara A Knowlden; Terry W Wright; William J Bowers
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

Review 5.  Hematopoietic stem cell: self-renewal versus differentiation.

Authors:  Jun Seita; Irving L Weissman
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

Review 6.  Megakaryocyte biology and related disorders.

Authors:  Liyan Pang; Mitchell J Weiss; Mortimer Poncz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

7.  The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis.

Authors:  R Shaknovich; P L Yeyati; S Ivins; A Melnick; C Lempert; S Waxman; A Zelent; J D Licht
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Phorbol 12-myristate 13-acetate-mediated signalling in murine bone marrow cells.

Authors:  D Visnjić; D Batinić; Z Lasić; M Knotek; M Marusić; H Banfić
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  A human GM-CSF receptor expressed in transgenic mice stimulates proliferation and differentiation of hemopoietic progenitors to all lineages in response to human GM-CSF.

Authors:  I Nishijima; T Nakahata; Y Hirabayashi; T Inoue; H Kurata; A Miyajima; N Hayashi; Y Iwakura; K Arai; T Yokota
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

10.  A distinct "side population" of cells with high drug efflux capacity in human tumor cells.

Authors:  C Hirschmann-Jax; A E Foster; G G Wulf; J G Nuchtern; T W Jax; U Gobel; M A Goodell; M K Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.